Clinical Trials

Showing trials with last updates posted in 2026.

NCT06696768 | RECRUITING | PHASE1
24 participants

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2025-06-23
Completion:
2026-12-31
Conditions
  • Metastatic Colorectal Adenocarcinoma
  • Stage III Colorectal Cancer AJCC v8
  • Stage IV Colorectal Cancer AJCC v8
  • Unresectable Colorectal Adenocarcinoma
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • DRUG
No Results Yet
NCT06661915 | RECRUITING | PHASE2
78 participants

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2025-08-14
Completion:
2027-12-31
Conditions
  • Accelerated Phase Myeloproliferative Neoplasm
  • Blast Phase Myeloproliferative Neoplasm
  • Essential Thrombocythemia
  • Myelodysplastic/Myeloproliferative Neoplasm
  • Myeloproliferative Neoplasm, Not Otherwise Specified
  • Polycythemia Vera
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT06590467 | RECRUITING
2500 participants

Abbott Structural Heart Device Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-01
Start Date:
2024-08-21
Completion:
2029-12-31
Conditions
  • Heart Diseases
  • ASD - Atrial Septal Defect
  • VSD - Muscular Ventricular Septal Defect
  • PFO - Patent Foramen Ovale
  • PIVSD - Post Infarct Muscular Ventricular Septal Defect
  • Valvular Heart Disease
Interventions
  • DEVICE
No Results Yet
NCT06580080 | SUSPENDED | NA
1850 participants

Evaluation of Are You Ready?

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2024-11-15
Completion:
2028-08-31
Conditions
  • Teen Pregnancy Prevention
Interventions
  • BEHAVIORAL
No Results Yet
NCT06574139 | SUSPENDED | NA
1500 participants

Evaluation of Unstained

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2024-09-16
Completion:
2028-03-31
Conditions
  • Teen Pregnancy Prevention
Interventions
  • BEHAVIORAL
No Results Yet
NCT06568172 | SUSPENDED | PHASE3
420 participants

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2025-02-18
Completion:
2031-08-14
Conditions
  • Eyelid Squamous Cell Carcinoma
  • Recurrent Eyelid Squamous Cell Carcinoma
  • Recurrent Skin Acantholytic Squamous Cell Carcinoma
  • Recurrent Skin Clear Cell Squamous Cell Carcinoma
  • Recurrent Skin Lymphoepithelial Carcinoma
  • Recurrent Skin Spindle Cell Squamous Cell Carcinoma
  • Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation
  • Resectable Eyelid Squamous Cell Carcinoma
  • Resectable Skin Acantholytic Squamous Cell Carcinoma
  • Resectable Skin Clear Cell Squamous Cell Carcinoma
  • Resectable Skin Lymphoepithelial Carcinoma
  • Resectable Skin Spindle Cell Squamous Cell Carcinoma
  • Resectable Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation
  • Skin Acantholytic Squamous Cell Carcinoma
  • Skin Clear Cell Squamous Cell Carcinoma
  • Skin Lymphoepithelial Carcinoma
  • Skin Spindle Cell Squamous Cell Carcinoma
  • Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation
  • Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • RADIATION
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page